Nutraceutical consumer startup The Good Bug has raised Rs 100 crore ($11.8 million) in new funding from Susquehanna Asia VC along with participation from existing investor Fireside Ventures.

The company will utilise the funds to expand its reach, hiring, research & development, and marketing.

Commenting on the funding, Keshav Biyani, co-founder of The Good Bug in a statement said, “This new capital infusion will be pivotal in accelerating our research and development efforts, driving groundbreaking innovations in gut health through rigorous R&D. Additionally, we will bolster our marketing and distribution strategies to enhance consumer awareness and expand our reach across India. Attracting top-tier talent across research, technology, science, and business will further strengthen our foundation.”

Bhavani Rana, investment advisor to Susquehanna Asia VC added, “What sets TGB apart is the strength of its leadership team and their exceptional ability to execute on their vision. With strong momentum and a clear strategy, the company is well positioned to capitalize on the macro tailwinds of India’s rapidly expanding nutraceuticals market.”

Founded in 2022 by Keshav Biyani and Prabhu Karthikeyan, The Good Bug offers wellness products across various categories.

Author Credits- Maverick Martins, FASHION NETWORK